Showing results (31-40 of 382) with videos related to

Sort By:
Pageof 39
Radiologie (Heidelberg, Germany)|February 6, 2026
[Imaging-based response criteria in oncology : Assessment of response to treatment in solid tumors and lymphomas]Lynn Jeanette Savic, Jörg Westermann, Annika Kurreck, et al.
Bioinformatics (Oxford, England)|June 29, 2017
Partitioned learning of deep Boltzmann machines for SNP dataMoritz Hess, Stefan Lenz, Tamara J Blätte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cellsJochen Greiner, Lars Bullinger, Barbara-ann Guinn, et al.
Med (New York, N.Y.)|December 7, 2024
Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profilingJana Ihlow, Livius Penter, Lam Giang Vuong, et al.
Cancers|April 12, 2022
Refining AML Treatment: The Role of Genetics in Response and Resistance Evaluation to New AgentsAdriane Halik, Christopher Maximilian Arends, Lars Bullinger, et al.
International Journal of Hematology|October 7, 2005
CD52 is not a promising immunotherapy target for most patients with multiple myelomaJörg Westermann, Georg Maschmeyer, Antje van Lessen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Granulocyte macrophage-colony stimulating factor plus interleukin-2 plus alpha-interferon plus 5-fluorouracil in the treatment of metastatic renal cell cancer: induction of CD80/86+ T cells indicates adverse outcomeJörg Westermann, Ann-Christine Hecker, Anne Flörcken, et al.
Oncology Research and Treatment|May 19, 2017
Novel Treatment Options in Head and Neck CancerPatrick J Schuler, Simon Laban, Johannes Doescher, et al.
Case Reports in Hematology|January 9, 2023
Relapse of NPM1-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell TransplantationJan Braune, Kathrin Rieger, Olga Blau, et al.
British Journal of Haematology|April 3, 2004
T cell recognition of bcr/abl in healthy donors and in patients with chronic myeloid leukaemiaJörg Westermann, Claudia Schlimper, Günther Richter, et al.
Pageof 39